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Background: Donor hepatectomy time is associated with graft survival after liver transplantation. The
aim of this study was to identify the impact of donor hepatectomy time on biliary injury during donation
after circulatory death liver transplantation.
Methods: First, bile duct biopsies of livers included in (pre)clinical machine perfusion research were
analyzed. Secondly, of the same livers, bile samples were collected during normothermic machine
perfusion. Lastly, a nationwide retrospective cohort study was performed including 273 adult patients
undergoing donation after circulatory death liver transplantation between January 1, 2002 and January 1,
2017. Primary endpoint was development of non-anastomotic biliary strictures within 2 years of dona-
tion after circulatory death liver transplantation. Cox proportional-hazards regression analyses were
used to assess the influence of hepatectomy time on the development of non-anastomotic biliary
strictures.
Results: Livers with severe histological bile duct injury had a higher median hepatectomy time (P ¼ .03).
During normothermic machine perfusion, livers with a hepatectomy time >50 minutes had lower biliary
bicarbonate and bile pH levels. In the nationwide retrospective study, donor hepatectomy time was an
independent risk factor for non-anastomotic biliary strictures after donation after circulatory death
liver transplantation (Hazard Ratio 1.18 per 10 minutes increase, 95% Confidence Interval 1.06e1.30,
P value ¼ .002).
Conclusion: Donor hepatectomy time negatively influences histological bile duct injury before normo-
thermic machine perfusion and bile composition during normothermic machine perfusion. Additionally,
hepatectomy time is a significant independent risk factor for the development of non-anastomotic biliary
strictures after donation after circulatory death liver transplantation.
© 2020 Elsevier Inc. All rights reserved.shared first authorship. Both
ert J. Porte and Wojciech G.




The imbalance between the number of patients on the waiting
list for liver transplantation (LT) and the number of available grafts
from donation after brain death (DBD) donors has resulted in an
increased use of livers from donation after circulatory death (DCD)
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were performed with a DCD graft.1
LT from DCD donors can lead to inferior outcomes compared
with LTwith DBD grafts, especially with respect to graft survival,2e5
which is related to a higher chance of developing early allograft
dysfunction and post-transplant cholangiopathy.6e10 Among post-
transplant cholangiopathies, non-anastomotic strictures (NAS),
also known as ischemic type biliary lesions or ischemic cholangi-
opathy, is the most hazardous type, with a strong negative impact
on graft survival.11e13
An important determinant of outcome after LT is ischemia
reperfusion injury. Ischemia reperfusion injury occurs in both DBD
and DCD-LT. However, DCD grafts suffer from an additional period
of warm ischemia in the donor between withdrawal of life support
and initiation of cold flush out, the so-called donor warm ischemia
time (dWIT). Several studies have indicated that the length of the
dWIT is a critical risk factor for negative outcome after DCD-LT.2,14,15
Unfortunately, the start of in situ cold flush out and cooling does
not lead to adequate protection against ischemic injury, because
the core temperature of the liver generally does not drop below 15
to 20oC during surgery.16 At this temperature, organs are still
metabolically active, resulting in rapid depletion of adenosine
triphosphate and accumulation of metabolites during anaerobic
metabolism. Liver core temperature first reaches a relatively safe
range (<4oC) when organs are stored in a bag with cold preserva-
tion solution in a box with ice. Therefore, it is hypothesized that,
apart from the dWIT, the duration of the hepatectomy time pro-
vides an additional risk factor for ischemic injury and could
therefore impact outcome after LT.
A recent study published by Jochmans et al and based on data
from the Eurotransplant Registry supported this hypothesis.17 In
this study, donor hepatectomy time was an independent risk factor
for patient mortality and graft loss. Moreover, DCD grafts appeared
to be more susceptible to donor hepatectomy time than DBD grafts.
More recently, Farid et al assessed the influence of the donor
hepatectomy time on the outcomes of DCD-LT in the United
Kingdom, concluding that a hepatectomy time of more than 60
minutes was associated with a higher risk of primary nonfunction
and graft failure.18 Neither study, however, assessed the effect of
donor hepatectomy time on the development of post-transplant
cholangiopathy after DCD-LT, neither did they evaluate whether
hepatectomy time was different among procurement teams.
Several studies have shown a strong relation between bile duct
injury (BDI) before implantation and the development of NAS after
transplantation.19,20 If donor hepatectomy time influences the rates
of NAS, this would be displayed in the severity of biliary injury
before implantation. Additionally, bile composition during
normothermic machine perfusion (NMP) of liver grafts can be
studied to assess bile duct injury.21,22
The aim of this study was to assess the impact of donor hepa-
tectomy time in DCD donors on the development of biliary injury
during DCD-LT. First, bile duct biopsies taken upon arrival in one of
the 3 recipient centers were analyzed. Secondly, bile composition
during NMP was studied. Last, the influence of hepatectomy time
on the development of NAS after DCD-LT was studied in a nation-
wide retrospective database study.
Methods
Donation procedure and organ procurement
Until recently, all donor procedures/procurements in the
Netherlands were performed by one of 5 regional procurement
teams, each covering a certain region of the country. Each pro-
curement team consists of a surgeon, surgical assistant,anesthesiologist, and 2 operation room assistants. In the
Netherlands, withdrawal of life support in a patient eligible for DCD
organ donation generally takes place at the intensive care unit.
Premortem cannulation of the patient is not performed, and sys-
temic heparinization is prohibited by Dutch law. When circulatory
arrest has been determined, there is a mandatory 5 minutes “no-
touch” period. After this “no-touch” period, the donor is trans-
ported to the operating theatre. A super-rapid sterno-laparotomy
with pressurized, aortic-only perfusion is used as the standard
procurement technique. Cold perfusion is currently executed with
Belzer UW Cold Storage Solution (Bridge to Life, London, UK).
Whether the liver is retrieved separately or en bloc with the
pancreas is based on the preferences of the surgeon. On the back
table, the liver is flushed via the portal vein with at least 500 mL
cold preservation solution until clear perfusate is established. The
common bile duct (CBD) and intrahepatic biliary tree are flushed
with low pressure Belzer UW Cold Storage Solution.23 As there are
no clear Dutch guidelines on the sequence of organ procurement,
the lungs in a DCD donor are usually procured before the abdom-
inal organs. The implantation is usually executed with a caval
sideclamp and veno-venous anastomosis, end-to-end arterial and
portal anastomosis, and duct-to-duct biliary anastomosis. The
standard reperfusion technique used is initial portal vein
reperfusion.
Study design
This study consists of 3 parts. First, bile duct biopsies and bile
composition of DCD livers were analyzed for a potential influence
of hepatectomy time (parts AeB). Hereafter, to validate the find-
ings, a nationwide retrospective database analysis was performed
(part C).
Part A: Histological analysis of bile ducts
Of all DCD livers that underwent preclinical and clinical NMP in
the University Medical Center Groningen between January 1, 2013
and January 1, 2019, bile duct biopsies before machine perfusion
were collected. The only criterion required for inclusion was that
the donor hepatectomy time was available. Biopsies were taken
from the distal CBD before machine perfusion, fixed in 4% formalin,
and subsequently embedded in paraffin. Slices of 4 mmwere cut and
stained with hematoxylin and eosin and subsequently examined
using light microscopy. The BDI score was determined in a blinded
fashion by 2 researchers, using a clinically relevant histological
grading system.20,22 The BDI consisted of the combined scores for
deep peribiliary gland injury, peribiliary vascular plexus injury, and
stroma necrosis. The cutoff value used between low and high BDI
was 4.75, as described previously.22 Comparisons between groups
were performed with the c2 test or Fisher exact test where
appropriate. Receiver operating characteristic curves were used to
identify the most appropriate cutoff values.
Part B: Normothermic machine perfusion
All preclinical and clinical NMP procedures were performed
with the Liver Assist device (Organ Assist, Groningen, the
Netherlands). Protocols and outcomes are reported else-
where.22,24,25 To monitor biliary tree viability, bile was collected
from an 8Fr biliary drain in the CBD. During NMP, bile samples were
collected every 30 minutes under mineral oil to determine biliary
pH, bicarbonate, and glucose, as these parameters are biomarkers
of bile duct viability.22 Bile compositionwas compared between the
groups at different time points using the Mann-Whitney U test.
Fig 1. Hepatectomy time influences biliary injury before transplantation. (A) Liver grafts with a high BDI score had a longer median hepatectomy time compared with livers with a
low BDI score (P ¼ .027). Data presented as median (IQR). (B) Livers grafts with a donor hepatectomy time >50 minutes have more severe BDI compared with livers with a
hepatectomy time 50 minutes (P ¼ .016). *Depicts a significant (P < .050) difference.
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In this nationwide retrospective cohort study, all adult LT
performed with a DCD graft in the Netherlands between January
1, 2002 and January 1, 2017 were included. Exclusion criteria were
multiorgan DCD transplants, DCD retransplantations, trans-
plantations involving machine perfusion, and procurement of
DCD grafts by a foreign procurement team. Additionally, cases
with missing information on hepatectomy times or donor agonal
phase were excluded. Donor characteristics and information on
the procurement procedure and the regional procurement team
were obtained via the Donor Data Application of Eurotransplant.
Data of recipients and transplantation outcomes were obtained
from the databases of the participating centers and were
completed with data from the patients’ electronic medical
records.
Donor hepatectomy timewas defined as the period between the
start of cold flush in the donor and the storage of the liver in a bowl
with cold preservation fluid and melting ice on the back-table. The
dWIT was calculated as the time between withdrawal of life sup-
port and cold flush in the donor. Since in the normal situation the
donor hepatectomy time is part of the cold ischemia time, the
definition of the cold ischemia time has been altered to minimize
the chance of confounding; cold ischemia time was defined as the
period between the end of the donor hepatectomy and the removal
of the liver from ice before implantation. Finally, recipient warm
ischemia timewas defined as the time between removal of the liver
from ice until either portal or arterial reperfusion, whichever came
first.
The endpoint of the retrospective study was the development of
NAS within 2 years after transplantation. NAS was defined as donor
bile duct strictures at any location but the anastomosis, in absence
of hepatic artery thrombosis. To meet the endpoint, patients were
required to have clinical symptoms of cholestasis (eg, jaundice, itch,
elevated total bilirubin) with subsequent imaging demonstrating
bile duct strictures. If NAS developed after 2 years, it was consid-
ered to be related to recipient factors rather than donor factors.
Univariable and multivariable Cox proportional-hazards regression
models were used to evaluate independent risk factors for NAS. In
bothmodels, subjects that did not develop NAS within 2 years were
censored at 2 years post transplantation. Patients who died or
underwent retransplantation within the first 2 years after trans-
plantation were censored at their date of death or date of retrans-
plantation, respectively. Variables were included in themultivariable, backward stepwise, Cox model if univariable Cox
regression yielded a P value <.20. The threshold of .20 was chosen
to decrease the risk of overfitting of the model. The reported hazard
ratios (HR) for donor hepatectomy time refer to an increase of 10
minutes in hepatectomy time. For the cold ischemia time and
recipient warm ischemia time, the HR represent an increase of 1
hour and 1 minute, respectively.
In all 3 projects incorporated in this study, continuous variables
were presented as median with both total range and interquartile
range (IQR), whereas categorical variables were presented as
number [percentage]. All tests had a 2-sided design with a P value
below .05 considered significant. The analyses were performed
using SPSS version 24 (IBM Corporation, Chicago, IL). This studywas
approved by the Medical Ethical Committee of the University
Medical Center Groningen (METC.2017/504).Results
Part A: Histological analysis of the bile duct
Of 40 consecutive NMP procedures between 2013 and 2019,
39 bile duct biopsies were collected. After exclusion of biopsies
with an unknown donor hepatectomy time, 27 biopsies were
included in the analysis. Livers with a high BDI score had a
significantly longer median donor hepatectomy time compared
with grafts with low BDI score (56 vs 44 minutes, P ¼ .03) (Fig 1,
A). Receiver operating characteristic-curve analysis showed a
donor hepatectomy time of 50 minutes as the most suitable
cutoff point. Of livers with hepatectomy time 50 minutes, 17%
displayed high BDI vs 64% in livers with a hepatectomy time >50
minutes (P ¼ .01) (Fig 1, B).Part B: Normothermic machine perfusion
Of the 27 livers, livers with a hepatectomy time 50 minutes
had more alkalotic bile during the first 4 hours of NMP. Subse-
quently, biliary bicarbonate levels were higher in livers with a
hepatectomy time below 50 minutes. (Fig 2, AeB). Glucose reab-
sorption, displayed by the glucose ratio between bile and perfusate,
did not seem to be significantly influenced by hepatectomy time
(Fig 2, C).
Fig 2. Hepatectomy time influences bile composition during NMP. (A) Hepatectomy time influenced biliary bicarbonate levels during NMP. (B) Bile pH was significantly lower in the
group with hepatectomy time 50 minutes. (C) Hepatectomy time did not seem to significantly influence biliary glucose reabsorption. *Depicts a significant (P < .050) difference.
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A total of 376 DCD-LTs were performed in the Netherlands be-
tween January 1, 2002 and January 1, 2017. One hundred and three
cases met 1 or more of the exclusion criteria, resulting in a total of
273 included in this study (Fig 3). The median follow-up period of
the complete cohort was 4.36 years (IQR 2.81e7.08, range 0e16.8
years). Baseline characteristics are presented in Table I. Median
donor hepatectomy time for the entire cohort was 63 minutes (IQR
52.5e80.5, range 23e140 minutes). Lung procurement led to a
significantly longer donor hepatectomy time of 69 minutes (IQR
59e80 minutes), when compared with a hepatectomy time of 61
minutes (IQR 49e81 minutes) in donors in which lungs were not
procured (P ¼ .02). The outcomes after DCD-LT in the completeFig 3. Flow chart of included subjects icohort are shown in Table I. Actuarial 1-, 3-, and 5-year graft sur-
vival rates were 75%, 64%, and 60%, and 87%, 79%, and 74% for pa-
tient survival, respectively.
Sixty-six patients (24.2%) were diagnosed with NAS within 2
years of LT. During the complete follow-up, 25 patients have un-
dergone a retransplantation as a result of this complication. Base-
line characteristics, stratified by recipient development of NAS, are
provided in supplementary Table I. In a univariable Cox
proportional-hazards regression model, donor hepatectomy time
was an independent risk factor for the development of NAS (HR
1.14, 95% confidence interval [CI] 1.03e1.26, P value .02). After
adjusting for all covariates with a P value below .2 in univariable
analyses, donor hepatectomy time remained an independent risk
factor for developing NAS within the first 2 years post LT (adjustedn the retrospective database study.
Table I
Donor and recipient demographics
Characteristic Result (N ¼ 273)
Donor





Body mass index (kg/m2) 24.0 (22.0e26.0)
Range 13e34
CVA as cause of death
No 151 [55.3%]
Yes 122 [44.7%]
ALT peak (U/L) 43.0 (23.0e87.0)
Range 6e7,385
Last gGT (U/L) 34.0 (20.0e65.5)
Range 4e747
Procurement
Donor warm ischemia time (min)* 32.0 (26.0e38.0)
Range 15e80
Donor hepatectomy time (min)y 63.0 (52.5e80.5)
Range 23e140
Lung procurement 84.0 [30.8%]
Recipient





Body mass index (kg/m2) 25.7 (23.4e29.1)
Range 17e46
HCC as indication for transplantation
No 175 [64.1%]
Yes 98 [35.9%]
Laboratory MELD score 14.6 (10.0e21.0)
Range 6e44
Transplantation
Cold ischemia time (min)z 359 (302e431)
Range 131e743
Recipient warm ischemia time (min)x 34.0 (26.0e42.0)
Range 17e144
Outcomes
AST peak (u/L) 2,115 (1,165e4,252)
Range 129e20,280
ALT peak (u/L) 1,620 (771e2,857)
Range 162e10,944
Intensive care unit stay (d) 2.0 (1.0e5.0)
Range 0e185
Total hospital stay (d) 18.0 (13.0e27.0)
Range 0e235
Primary non-function|| 8 [2.90%]
Non-anastomotic strictures 70 [25.6%]
Within 2 y post-transplantation 66 [24.2%]









Values are presented as median (IQR) or number [%].
ALT, alanine aminotransferase; AST, aspartate aminotransferase; CVA, cerebrovas-
cular accident; gGT, gamma-glutamyl transferase; HCC, hepatocellular carcinoma;
MELD, model for end-stage liver disease.
* The time between withdrawal of life support and cold flush in the donor.
y The period of time between the start of cold flush in the donor and the storage of
the liver on ice on the back table.
z The time between the end of the donor hepatectomy and the removal of the
liver from ice before implantation.
x The time between removal of the liver from ice until either portal or arterial
reperfusion.
|| Patient death or retransplantation within 7 days of transplantation without
clear cause.
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hepatectomy time, donor age and cold ischemia time were signif-
icant risk factors for NAS.
Discussion
This is the first study that demonstrates the impact of
donor hepatectomy time on the development of biliary injury
during and after DCD liver transplantation. Hepatectomy
time influences the severity of histological BDI before
transplantation. Moreover, prolonged hepatectomy times nega-
tively influences bile composition during NMP. Additionally, the
retrospective study indicates that every 10-minute increase in
donor hepatectomy time leads to an 18% increase in the risk of
developing NAS.
Op den Dries et al have shown that bile duct histology is
highly predictive of NAS after liver transplantation.20 In the
current study, it is observed that prolonged hepatectomy times
leads to an increased BDI score, depicting increased rates of deep
peribiliary gland injury, peribiliary vascular plexus injury, and
stroma necrosis. The results from this histology study demon-
strate that the impact of hepatectomy time is already visible
before graft reperfusion. In addition to histology, NMP can be
used to assess biliary function.21,22 Similar results were observed
during NMP; livers with prolonged hepatectomy time produced
bile of inferior quality.
The results of the current study are roughly in line with those
reported in the Eurotransplant registry study by Jochmans et al and
the United Kingdom-based study from Farid et al: a prolonged
donor hepatectomy time impairs the outcome of DCD-LT. However,
neither of the studies were able to assess the influence of donor
hepatectomy time on the development of biliary complications.
Surprisingly, the median donor hepatectomy time in the Dutch
cohort in the current studywas substantially longer than that of the
DCD-LT subgroup in the study of Jochmans et al (63 vs 50 mi-
nutes).17 As within the Eurotransplant region, only the Netherlands,
Belgium, and Austria perform DCD organ procurements; this im-
plies that the donor hepatectomy time in the Netherlands is sub-
stantially longer compared with the other 2 countries. Moreover,
the median hepatectomy time in our cohort was also considerably
longer than in the United Kingdom as reported by Farid et al (63 vs
35 minutes).18 As a result of this finding, the Dutch Committee on
Independent Procurement Teams implemented several strategies
to lower the hepatectomy time, such as raising awareness on the
impact of the donor hepatectomy time and endorsing knowledge
and skill exchange between the teams. Since 2018, this has resulted
in a substantial decrease of the donor hepatectomy time in the
Netherlands (mean of 42 minutes with a standard deviation of 12
minutes) without an increase in liver injuries, highlighting the
importance of training in organ procurement and regular
evaluation.26
The graft survival rates reported by Farid et al are substantially
higher than those in our cohort (1-, 3-, and 5-year graft survival of
86.5%, 80.9%, and 77.7% in the United Kingdomvs 75%, 64%, and 60%
in the Dutch cohort, Table I). Since the patient survival rates have
not been reported by Farid et al, it is not possible to evaluate
whether the higher rate of graft loss in the Netherlands is the result
of more patient deaths or of more retransplantations. However, it
could possibly be explained by the difference in hepatectomy time
between the 2 cohorts. Nevertheless, it would be valuable to
thoroughly investigate this substantial difference in graft survival
rates.
Surprisingly, procurement of the lungs seemed to have a pro-
tective effect on the development of NAS, despite the fact that lung
Table II
Univariable Cox proportional-hazards regression model for developing NAS
Hazard ratio 95% CI P value
Donor
Age (y) 1.03 1.01e1.05 .004
Sex
Male REF
Female 1.14 0.70e1.86 .59
Body mass index (kg/m2) 0.99 0.92e1.08 .88
CVA as cause of death
No REF
Yes 1.83 1.13e2.98 .02
ALT peak (U/L) 1.00 1.00e1.00 .09
Last gGT (U/L) 1.00 1.00e1.00 .41
Procurement
Donor warm ischemia time (min)* 1.03 1.01e1.05 .01
Donor hepatectomy time (10 min)y 1.14 1.03e1.26 .02
Lung procurement 0.60 0.34e1.06 .08
Recipient
Age (y) 0.994 0.97e1.02 .60
Sex
Male REF
Female 1.22 0.72e2.07 .45
Body mass index (kg/m2) 1.02 0.97e1.07 .55
HCC as indication for transplantation
No REF
Yes 0.77 0.46e1.30 .33
Laboratory MELD score 0.98 0.95e1.02 .35
Transplantation
Cold ischemia time (h)z 1.17 1.04e1.33 .01
Recipient warm ischemia time (min)x 1.02 1.00e1.04 .17
Values are presented as median (IQR) or number [%].
ALT, alanine aminotransferase; CVA, cerebrovascular accident; gGT, gamma-glutamyl
transferase; HCC, hepatocellular carcinoma; MELD, model for end-stage liver disease;
PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis.
* The time between withdrawal of life support and cold flush in the donor.
y The period of time between the start of cold flush in the donor and the storage of the
liver on ice on the back table.
z The time between the end of the donor hepatectomy and the removal of the liver
from ice before implantation.
x The time between removal of the liver from ice until either portal or arterial
reperfusion.
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probably the result of the strict acceptance criteria for DCD lung
donation handled by thoracic surgeons and lung physicians. OnlyTable III
Multivariable Cox proportional-hazards regression model for NAS
Hazard ratio 95% CI P value
Donor
Age (y) 1.03 1.01e1.05 .01
CVA as cause of death - - .29
No
Yes
ALT Peak 1.00 1.00e1.00 .05
Procurement
Donor warm ischemia time* - - .50
Donor hepatectomy timey 1.18 1.06e1.30 .002
Lung procurement 0.47 0.26e0.84 .01
Transplantation
Cold ischemia timez 1.22 1.08e1.38 .001
Recipient warm ischemia timex - - .47
Multivariable model was conducted via backward stepwise approach. A dash -
indicates that variable was removed from the model.
ALT, alanine aminotransferase; CVA, cerebrovascular accident; gGT, gamma-
glutamyl transferase.
* The time between withdrawal of life support and cold flush in the donor.
y The period of time between the start of cold flush in the donor and the storage
of the liver on ice on the back table.
z The time between the end of the donor hepatectomy and the removal of the
liver from ice before implantation.
x The time between removal of the liver from ice until either portal or arterial
reperfusion.lungs from optimal DCD donors are accepted, otherwise the lungs
are not procured. Lung procurement is in that case a proxy for a
more optimal donor.
Jochmans et al stated that portal perfusion, next to standard
in situ aortic cold flush, can accelerate liver cooling and might
prevent the detrimental effect of prolonged hepatectomy time.17
In a recent published study, Hameed et al concluded that in
high-risk DBD donors, dual perfusion is superior.27 Furthermore,
Ghinolfi et al concluded recently that dual perfusion has a pro-
tective effect on the development of ischemic type biliary lesions
after LT with grafts from octogenarian donors.28 However, a
randomized controlled trial comparing aortic flush only and
combined aortic and portal flush in DBD-LT, showed no differ-
ence in the incidence of post-transplant cholangiopathy.29 Since
DCD grafts could also be considered as high-risk grafts, it would
be justifiable to evaluate the effect of dual perfusion versus aortic
only perfusion in the DCD-LT population. Another method to
potentially minimize the detrimental effect of both dWIT and
hepatectomy time on the outcomes after LT is the use of
normothermic regional perfusion. A recently published study by
Hessheimer et al showed that with the use of normothermic
regional perfusion the rates of biliary complications and graft
loss could be reduced substantially when compared with a
super-rapid recovery.30
Recently, Kalisvaart et al showed the importance of the agonal
phase of the DCD donor and its influence on the outcomes after
transplantation, considering an arterial oxygen saturation level
below 80% as starting point for the functional donorwarm ischemia
O.B. van Leeuwen et al. / Surgery xxx (2020) 1e7 7time.31 Unfortunately, in our cohort, data on blood pressures and
saturation during the agonal phase were unavailable or improperly
recorded. Therefore, wewere forced to use another definition of the
donorwarm ischemia time. Since the agonal phase has proven to be
of importance, we chose to use the period between withdrawal of
life support and the initiation of cold flushing as the dWIT in this
study rather than the time between cardiac arrest and cold perfu-
sion. Additionally, as shown before, this study also underlines the
importance of a short cold ischemia time for DCD grafts.22.32 Every
hour of cold ischemia was associated with a 22% increased risk of
NAS. Finally, donor age is once again shown to be an important risk
factor for biliary complications.
An important strength of this study is the fact that histological
analyses are combined with a study of bile composition during
NMP and a nationwide retrospective database study. Another
strength is that donor hepatectomy time is incorporated as a
continuous variable into the multivariable model rather than as a
dichotomous variable set around a certain cutoff for donor hepa-
tectomy time. This latter would have led to a loss of valuable in-
formation. Another strong aspect of this study is the follow-up of all
patients with detailed information on the development of biliary
complications. One limitation of the database study is the retro-
spective design and relatively small cohorts. In addition, as part C
was used to validate the findings in parts A and B, these cohorts
consist of different patients. Moreover, in a substantial number of
cases, hepatectomy time and/or dWIT was missing, leading to a
high exclusion rate. Since we could not guarantee these variables to
be missing at random, imputation of these variables was not
desirable. We do not suspect that our results were confounded by
this; however, bias cannot entirely be excluded.
In conclusion, donor hepatectomy time strongly influences
biliary injury during and after DCD-LT. The donor hepatectomy time
should be kept as short as possible, especially in the presence of
other risk factors such as an older donor or prolonged cold ischemia
time.
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